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THE PEREZ SYMPOSIUM

Carlos Perez has made significant and lasting contributions to the field of
radiation oncology. The symposium "Current Topics in Cancer Treatment"
honors Dr. Perez for his clinical, academic, and research expertise.

WHEN BREAST CANCER
BECOMES PART OF A WOMAN'S LIFE

An educational booklet and video produced by breast
cancer specialists at Washington University Medical
Center provides newly diagnosed breast cancer
patients with a straightforward, supportive approach
for addressing concerns about their disease.

LAUNCHING AN IMAGE STUDY OF
POLYCYSTIC KIDNEY DISEASE

After nearly a year in planning and development,
a multi-institutional study is evaluating the
accuracy of magnetic resonance imaging in
determining the progression of the most common
genetic kidney disorder—autosomal-dominant
polycystic kidney disease.

IMRT UPDATE

Armed with state-of-the art imaging equipment
and the best available computer planning system,
radiation oncologists are using a novel
radiation treatment called intensity modulated
radiation therapy to effectively treat head and
neck cancers while reducing significant side
effects, including xerostomia (dry mouth).

ON THE COVER: Ty Bae, MD, PhD, draws upon his expertise in body
imaging, as well as image analysis, quantification, and processing, as
he leads a National Institutes of Health study that eventually may affect
more than 600,000 people in the United States who have polycystic kidney disease. Photograph by Tim Parker.
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SPOT NEWS
Grigsby named
Teacher of
the Year
Perry Grigsby, MD, MBA,
professor of radiology, was
selected as the 2000 Radiation Oncology Teacher of the
Year, making him a threetime recipient of the award
(including 1991 and 1995).
The radiation oncology residents select the award recipient by nominating and voting
for the MIR faculty member
who makes a significant contribution to radiation oncology resident education
during the academic year.
During the presentation
of the award—traditionally
given each year in December— Imran Zoberi, MD, radiation oncology chief
resident 2000-2001, said
"Doctor Grigsby's teaching
abilities are known nationally, which is evident by the
number of out-of-state residents who come to the
Radiation Oncology Center
just to rotate through his
[Grigsby'sj gynecology
service."
Grigsby joined the MIR
faculty in 1986 as an assistant
professor of radiology, after
completing four years of
training in radiation oncology
(chief resident 1985-1986) at
Mallinckrodt Institute. He has
served as chief of the Radiation Oncology Center's gynecology service since 1987. As
changes in the healthcare
environment began to dramatically affect patient care,
Grigsby joined the growing
trend of physicians earning
business degrees and
received an MBA in 1990
from Olin School of Business
at Washington University in
St. Louis.

Grigsby is regularly
listed among the nation's
medical experts in references such as The Best
Doctors in America, Who's
Who in Medicine and
Healthcare, and Guide to
Top Doctors. He has
authored and coauthored
more than 180 scientific articles and book chapters and
has served in editorial positions for several scientific
journals, including The
International Journal of
Radiation Oncology, Biology, and Physics.
Grigsby has served
since 1993 as chairman of
the Radiation Therapy
Oncology Group's Economic
Impact Committee, chaired
the American Society of
Therapeutic Radiation
Oncology's Long Range Planning Committee from 1988 to
1996, and was appointed in
2000 to the Gynecologic
Task Force of the American
Joint Committee on Cancer.
He is a member of several
medical organizations,
including the American Society of Clinical Oncology and
the American Brachytherapy
Society, and is a fellow of
the American College of
Radiology.
Since the award's
inception in 1989, the
following faculty have been
selected as teacher of
the year:
• 1989—Susan Shapiro, MD
• 1990—Carlos Perez, MD
• 1991, 1995, 2000—Perry
Gi-igsby, MD, MBA
• 1992—Jeff Michalski, MD
• 1993—Russell Gerber, MS
• 1994—Mary Graham, ML
• 7996—James Purdy, PhD
• 1997—Marie Taylor, MD
• 1998—David Gius, MD, Phi'
• 1999-^Jeffrey Bradley, Ml
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Kotner elected
A.CR fellow
In recognition for his disinguished accomplishments
n service and teaching,
jawrence Kotner, MD, associite professor of radiology,
NZS elected a fellow of the
American College of Radiology (ACR). The induction
ceremony will be held in
September during the ACR's
78th Annual Meeting in San
Francisco.
The ACR, comprised of
more than 30,000 radiologists,
n—radiation oncologists, and
medical physicists, supports
IUC
programs focusing on the
practice of radiology and the
id
delivery of comprehensive
radiological health services,
an'ellowship is one of the
1 to
\CR's highest honors given to
n
ts members.
Kotner joined the MIR
in
acuity in 1975 and has served
>r.
as course master for the
Senior Medical Student Radiology Elective since 1988. He
was director of the Radiology
Residency Program at Jewish
Hospital from 1989 to 1994,
when the program merged
with Barnes Hospital's training program. He now serves
as associate director of
Vlallinckrodt Institute's fouryear diagnostic radiology
n
training program, the largest
of its kind in the United
States.
ID
In 1989 and in 1991, he
received Washington Univerity's Sydney S. Pearl MD '32
Award for Inspirational
Teaching. In recognition of
|tis leadership quality and
pmportant contributions to
pedical student and radiology resident education, Kotner was elected in 1998 as an
alumni member of the Washington University Chapter of
Alpha Omega Alpha Honorary
[Medical Society.
vs
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Perez receives
national
cancer award
Carlos Perez, MD, professor of radiology and
director of the Radiation
Oncology Center, received
The National Children's Cancer Society Legacy Award
2001 for his "significant and
lasting contributions in the
fight against cancer" and for
his "exceptional and distinguished leadership in the
field of radiology." The
award was presented in
March at the Society's International Humanitarian
Award Dinner 2001.
Founded in 1987, The
National Children's Cancer
Society is a not-for-profit
organization that provides
direct financial assistance to
children with cancer and to
their families. Headquartered in St. Louis, the Society was founded on the
belief that no child with cancer should be denied access
to quality medical care
because of a lack of funds.
Perez's career spans
four decades, and during
those years he has become
one of the most highly
regarded radiation oncologists in the world, particularly in the management of
patients with gynecologic
tumors and carcinoma of the
prostate and of the breast.
Perez tends not only to the
physical needs of patients
but also to their emotional
and psychological needs. He
has received numerous
recognitions, including the
American College of Radiology's Gold Medal Award and
the American Society for
Therapeutic Radiology and
Oncology's Gold Medal.

WUSM among
top five in U.S.

Perez joined the MIR
faculty in 1964 and was
named director of the Radiation Oncology Center in
1976. Under his leadership,
the Radiation Oncology Center is a premier radiation
treatment center with a
strong research core. In 1977
Perez established the Cancer
Information Center (CIC) for
patients and their families
and friends, as well as for
physicians. The CIC was the
first resource facility of its
kind worldwide and has
served as a model for similar
centers in the United States
and abroad.

Washington University
School of Medicine (WUSM)
was named one of the top five
medical schools for research
in the United States, according to the U. S. News & World
Report 2001 annual rankings
of best graduate schools.
WUSM ranked fourth (tied
with University of Pennsylvania), following Harvard, Johns
Hopkins, and Duke.
Now in its fifteenth
year, U. S. News & World
Report rankings are based
on varying criteria, including
a school's reputation,
research activity, student
selectivity, and academic
surveys.

Matching
Program
results
announced
As part of the Matching
Program, 17 physicians are
slated to join MIR's Diagnostic Radiology Residency
Program; one of the 17 will
participate in the Research
Residency Program. These
promising young trainees
represent excellent medical
schools: Yale University,
Johns Hopkins University,
University of California at
San Francisco, Saint Louis
University, Medical College
of Virginia, Texas Tech University, University of South
Florida, Northwestern University, University of Wisconsin,
Hahnemann University, University of Alabama, University
of North Carolina, University
of Arizona, and Washington
University in St. Louis.
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Mintun
appointed to
Center for
Scientific
Review
Mark Mintun, MD, professor of radiology and of psychiatry, was appointed to a
three-year term as a member of
the Integrative, Functional and
Cognitive Neuroscience Study
Section of the Center for Scientific Review, sponsored by the
National Institutes of Health
(NIH). Founded in 1887, the
NIH is one of the world's foremost medical research centers.
It is comprised of 25 separate
institutes and centers that focus
on acquiring knowledge to help
prevent, detect, diagnose, and
treat disease and disability.
Center for Scientific
Review members are selected
on the basis of demonstrated
competence and achievement
in their scientific discipline, as
evidenced by the quality of
their research accomplishments and scientific publications. Study sections
contribute to the national biomedical research effort by
reviewing grant applications
submitted to the NIH and then
making recommendations to
the appropriate NIH national
advisory council or board.
After completing a
research fellowship in neurology at Washington University
and a nuclear medicine residency at Mallinckrodt Institute,
Mintun joined the MIR faculty
in 1985 as an assistant professor of radiology. In 1989 his
research took him to the University of Michigan and then to
the University of Pittsburgh.
He returned to MIR in 1997 to
continue his research using
positron emission tomography
to study the metabolic needs of
the brain during the neural
process and to investigate
the biology of depression
treatment.

Welch dedicates Imaging Center
In June of 1999,
Yoshiharu Yonekura, MD, director of the High Energy Medical
Research Center at Fukui
Medical University, and
Ronald Evens, MD, then director of the Institute, signed a
five-year academic exchange
and cooperation agreement
(one copy in English, the
other in Japanese) between
the two institutions. Michael
Welch, PhD, professor of radiology and of chemistry and
codirector of the Division of
Radiological

Sciences, was instrumental in coordinating the exchange of
researchers and
scientific information,
materials, and
publications
necessary for the joint
research activities.
Welch's long-time
collaboration with the
Japanese university on
radiopharmaceutical research
includes the development of
an imaging agent for hypoxia
that was used in clinical
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studies at Mallinckrodt
Institute. He recently travelled |
to Japan to participate in the
dedication of the Biomedical
Imaging Research Center at
Fukui Medical University.

Welch (third from right) and other Fukui University officials cut the ceremonial ribbon at the opening of the new imaging center.
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HE PEREZ SYMPOSIUM
CURRENT TOPICS IN
CANCER TREATMENT

^Dr. IPereZ is being honored for his many contributions to
the scientific knowledge of radiation oncology in the education of
radiation oncologists, physicists,
dosimetrists, nurses, and therapists, and for the highest quality
clinical care he has provided for
more than 40 years to thousands of
patients. We hope you will attend
this symposium in recognition of
Dr. Perez.
THERE IS NO CHARGE FOR THE
SYMPOSIUM, LUNCH, OR RECEPTION.
PRE-REGISTRATION IS ENCOURAGED
TO GUARANTEE SEATING; HOWEVER,
REGISTRATION AT THE DOOR WILL
BE ACCEPTED.

program
7:30 a.m.—8:00 a.m.
Registration and Continental Breakfast in the Newman Center Lobby

On honor of Carlos U^erez, uWD,
professor of radiology and
director of the Radiation Oncology Center.

Jriday • £June I, 2001
7-'^0 a.m. to S-'^O p.m.

Sponsored by
Washington University School of Medicine in St. Louis
Mallinckrodt Institute of Radiology
The Radiation Oncology Center

[yield at
The Eric P. Newman Education Center
320 South Euclid Avenue (on the medical center campus)

8:00 a.m.—8:15 a.m.
Welcome
8:15 a.m.—8:45 a.m.
Proton Radiation: The Ultimate in
External Beam Therapy?
Herman Suit, MD
Chairman Emeritus
Department of Radiation Oncology
Harvard University
8:45 a.m.—9:15 a.m.
Cardiovascular Radiation:
The New Frontier
Philip Rubin, MD
Chairman Emeritus
Department of Radiation Oncology
University of Rochester
9:15 a.m.—9:45 a.m.
Radiation Therapy for Benign
and Not So Benign Disease
Luther Brady, MD
Professor and Chairman Emeritus
Department of Radiation Oncology
Hahnemann University

iProcjram continued
9:45 a.m.—10:15 a.m.
Alpha/Beta Really Is Small for
Prostate Tumors
Jack Fowler, DSc, PhD
Department of Human Oncology
University of Wisconsin
10:15 a.m. -10:30 a.m.
Break
10:30 a.m.—11:00 a.m.
MultidiscipUnary Therapy
ofPediatric Cancer
Teresa Vietti, MD
Professor Emeritus
Pediatric Oncology
Washington University in St. Louis
11:00 a.m.—11:30 a.m.
Combined Modality Therapy
at Cervical Center
William Hoskins, MD
Chief, Gynecologic Oncology
Memorial-Sloan Kettering
Cancer Center
11:30 a.m.—12 noon
Combined Modality Therapy for
Head and Neck Cancer
Bahman Emami, MD
Professor and Chairman
Department of Radiation Therapy
Loyola University
12 noon—12:30 p.m.
Metastatic Bone Cancer
William Powers, MD
Radiation Oncology
Professor Emeritus
Sarasota, Florida
12:30 p.m.—1:30 p.m.
Box lunch provided at
Newman Center
1:30 p.m.—2:00 p.m.
MultidiscipUnary Treatment of
Breast CancerBernard Fisher, MD
Professor, Department of Surgery
Allegheny University
of the Health Sciences
2:00 p.m.—2:30 p.m.
Clinical Uses of
Chemotherapy/Radiotherapy
John Durant, MD
past Executive Director of the
American Society of Clinical Oncology

2:30 p.m.—3:00 p.m.
Benefits of Improved Accuracy in
Radiation Treatment of Prostate
Cancer
Gerald Hanks, MD
Chairman
Department of Radiation Oncology
Fox Chase Cancer Center
3:00 p.m.—3:15 p.m.
A Phase II Study of Gemcitabine .
Combined with Radiation Therapy
in Patients with Localized Unresectable Pancreatic Cancer
Avraham Kuten, MD
Professor and Head
Radiotherapy Unit
Rambam Medical Center
Haifa, Israel

^Registration
THERE IS NO CHARGE FOR THE
SYMPOSIUM, LUNCH, OR RECEPTION. PRE-REGISTRATION IS
ENCOURAGED TO GUARANTEE
SEATING; HOWEVER, REGISTRATION
AT THE DOOR WILL BE ACCEPTED.

Please respond by May 22, 2001,
by mailing this registration to
Washington University School
of Medicine, Office of Special
Programs, Campus Box 8512,
660 Euclid Avenue, St. Louis,
MO 63110-9825.
Or register by calling The
Office of Special Programs
at 314-286-0073.

3:15 p.m.—3:30 p.m.
New Directions in the Management
of Rectal Cancer
Vincenzo Valentini, MD
Professor Department of Radiotherapy
Catholic University
Rome, Italy

Please check the events you
will be attending.

3:30 p.m.—3:50 p.m.
Break

□

3:50 p.m.—4:20 p.m.
Cancer Centers in the 21st Century
Robert Young, MD
President
Fox Chase Cancer Center
4:20 p.m.—4:50 p.m.
The Significant Contributions of
Carlos A. Perez, MD
James Cox, MD
Chairman
Department of Radiation Oncology
M. D. Anderson Cancer Center

Symposium
Number of persons
attending

Name(s)_

□

Lunch
. Number of persons
attending

Name(s)_
4:50 p.m.—5:00 p.m.
The New Radiation
Oncology Center
Todd Wasserman, MD
Professor of Radiology
Mallinckrodt Institute of Radiology
at Washington University in St. Louis
5:00 p.m.—5:30 p.m.
Final Remarks
5:30 p.m.—7:00 p.m.
Reception
New Radiation Oncology Center
Alvin J. Siteman Cancer Center
4921 Parkview Place, Lower Level

□

Reception
Number of persons
attending

Name(s)_

when Breast Cancer

Becomes Part of a
Woman's Life
Breast cancer specialists
provide straightforward,
supportive resources
that address concerns
accompanying a diagnosis
of breast cancer.

hen a woman is told she has
breast cancer, it is often a
terrifying time, causing her to
rush to the library, the Internet,
and other resources to become better informed and to calm
her fears. The resources available do not always meet a
woman's needs, though, as Deborah Price will agree.

by Barbra Rodriguez

Diagnosed with breast cancer
in 1998, Price remembers the anxious moments spent in the waiting
room of a local breast imaging center before her cancer diagnosis was
confirmed. "What I remember seeing when I was having a second
mammogram was a videotape that
was really impersonal and rather
sad," Price says, adding that she
had no one with her to help process
that experience.
Now thanks to women like
Price, a team of physicians from
Mallinckrodt Institute of Radiology,
and the staff of the Barnes-Jewish
Hospital Breast Health Center, a
new booklet and companion video
are available to provide a straightforward, supportive approach for
addressing concerns that arise
when breast cancer becomes part
of a woman's life.
The factual booklet, "One Step
at a Time," covers a host of topics
in 10 brief chapters. The first five
chapters focus on basic breast cancer facts and myths, health team
members, treatment types, and
what to expect from breast reconstruction surgery.
Chapters 6 through 8 address a
woman's feelings after diagnosis,
her legal and other rights, and what
she can expect in follow-up care.
To round out the booklet, a
glossary and list of support groups
are included, as well as a pocket on
the back page for storing information. All of this, plus illustrations,
comes in a span of 32 pages that
can fit inside a woman's handbag.
"We really wanted something that
was useful and easy to read. Infor-

mation that could be used in time
of need, when the patient is too distraught to sit down and plough
through a lengthy book," says
Maria Schmidt, MD, assistant professor of radiology, who directed
the project to produce the booklet
and video.
The 8-minute video, "Between
Friends," delves into emotional
issues, using breast cancer survivors and medical specialists to
convey six core messages. These
include reminders that many
women do survive breast cancer,
they should not be afraid to ask
questions, and they should be practical in their expectations of themselves during treatment. A positive
attitude also is emphasized, as are
the importance of developing a
support team, celebrating life, and
moving on after being diagnosed.
The booklet and video are the
culmination of more than a year of
work by Schmidt; Dione Farria,
MD, MPH, assistant professor of
radiology; and Jill Bokern, RN,

MALLINCKRODT INSTITUTE OF RADIOLOGY

nurse coordinator of the Breast
Health Center. They received a
grant from the St. Louis affiliate of
the Susan G. Komen Breast Cancer
Foundation, Inc., to develop the
educational material. The grant
also covered production of 1,000
copies of the booklet and 1,000
copies of the video, which are
available through the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington
University School of Medicine. The
booklet information also is on-line
at www.barnesjewish.org.
The breast cancer specialists
say conversations with patients—
particularly minority women and
those with little formal education—convinced them to create the
material. Many of these women
locally receive cancer treatment
through the Breast Health Center
at Barnes-Jewish Hospital.
But these educational materials are appropriate for all women
who are newly diagnosed with
breast cancer. As Farria notes
about other breast cancer books,
"Some of them, frankly, would be
overwhelming even for a physician
who had been recently diagnosed
with the cancer."
Schmidt echoes that concern
and says that hearing a diagnosis of
cancer causes many women to go
into shock. "Some of the normal
cognitive functions just shut
down," she says. "We wanted to
emphasize the importance of asking questions and of bringing someone along to the doctor

appointments who can help the
patient ask questions and remember the answers and maybe take
some notes. Although the
doctor may explain choices and
recommendations at length, the
patient often cannot remember
what was said because her anxiety
level is so high."
Farria started the project
before she officially came to
Mallinckrodt Institute in November
of 1999. After arriving at MIR, she
collaborated with Schmidt and
Bokern on gathering ideas (with
the help of a resource collection
Bokern had developed) for their
own undertaking.
The trio also met one Saturday
in the spring of 2000 with the
Breakfast Club, a local support
group of African-American women
who have breast cancer. During a
breakfast meeting in the basement
of the Centennial Christian Church,
not far from the Washington University Medical Center, Deborah
Price and about a dozen other club
members shared their experiences
and the advice they would give
women. "They just opened up their
hearts and told us what they felt,"
Bokern said.
The women spoke about their
treatment concerns, how family
members reacted to their situation,
and other sensitive topics. And
they emphasized what had helped
them handle their breast cancer
diagnosis, such as being patient
with themselves and turning to
others for support.

f

Jill Bokern, RN
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Sherril Jackson, the club
president, said African-American
women frequently have trouble
accepting that last piece of advice,
since they often are in charge of
nurturing others. "It is a difficult
role for African-American women
to be the patient. I think it is really
hard for us to say that we need
some help."
In addition, the support group
emphasized the importance of celebrating life and staying active after
the diagnosis. Schmidt notes that
people define an active life in different ways. "For many of these
women, it has been involvement
in a breast cancer support group,
being active in the community,
such as the breast cancer community, helping others, or beginning a
new project."
The key comments of Breakfast Club members shaped the
topics in the video. Jackson and
some other club members also

were among those interviewed
in the video, which was designed
and produced—as was the
booklet—with pro bono assistance
by staff from Fleishman-Hillard
Inc., a St. Louis-based communications company.
For the video, the women were
asked questions and allowed to
give unrehearsed answers. Medical
specialists were interviewed using
this same approach. These specialists included Washington University School of Medicine's Virginia
Hermmann, MD, professor of
endocrine and oncologic surgery,
and Gerard Doherty, MD, associate
professor of endocrine and oncologic surgery and director of the
Breast Surgery Service at the
Breast Health Center. In addition,
Lannis Hall-Daniels, MD, a former
radiation oncology resident at
Mallinckrodt Institute, and Savannah Davis, LCSW, a social worker
at Barnes-Jewish Hospital, participated in the video.
To prepare the educational
booklet, Schmidt and her colleagues divided up the parts of
each chapter, focusing on brevity
and using simple language to convey what women should know.
Schmidt worked with the medical
illustration office (MedPIC) to
develop illustrations of breast
cancer concepts, reconstructive
surgery, and other subjects.
For example, a dandelion shedding its seeds was used to illustrate
cancer's ability to spread. The
image was borrowed from a previous cancer educational program,
"Learn, Share and Live," developed

by researchers at Mallinckrodt
Institute. The team also chose
some new illustrations, including
several of female models that they
hoped minority women would feel
comfortable viewing. "We really
wanted women who looked multicultural, who had typical, middleaged bodies," Schmidt said. "Not
someone with an idealized body
shape—like a Barbie doll."
[Barbut is a registered product ofMattel, Inc.]

To help ensure the booklet's
appropriateness, the team called on
a medical, a surgical, and a radiation oncologist plus a low-literacy
specialist to review it. Katherine
Jahnige, MD, instructor of obstetrics and gynecology and community outreach coordinator for the
Siteman Cancer Center, oversaw
an advance showing of the
"Between Friends" video to a
breast cancer support group for
African-American women sponsored by ConnectCare, the regional
health care safety net for the poor
and underinsured.
Schmidt and her colleagues did
not attend the advance showing for
fear that the women would be
reluctant to speak honestly in the
specialists' presence. Jahnige
received positive feedback, though,
and only minor changes were made
in the video.
A follow-up review of the educational materials began in March.
Bokern telephoned several dozen
women who had been diagnosed
very recently with breast cancer.
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The women, two thirds of whom
were from minority groups, were
asked if they would mind receiving
the video and the booklet by mail
and responding to a phone questionnaire a few weeks later. A
three-month review of the Web site
also is scheduled.
The trio have additional projects in the works, including educational flip charts that will help
breast cancer specialists provide
women with a better understanding
of what a biopsy, lumpectomy, and
other treatment options entail.
Farria notes that the team's
enthusiasm for that effort is partly
inspired by the resilient spirit of
the women who helped create the
booklet and video. "While some of
the women were still going through
issues of continued treatment or a
tumor recurring, they were working actively with the American Cancer Society or helping us with the
project. They were amazing." EH
The Breakfast
Club played an
important role in the
production of the
booklet and video.
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Ill 1998, Ty Bae, MD, PhD, assistant
professor of radiology, was selected as a
principal investigator for a Data Coordinating
and Image Analysis Center in a five-year,
multicenter study to use magnetic resonance
imaging (MRI) and ultrasound (US) imaging
for assessing the progression of autosomaldominant polycystic kidney disease (PKD).
PKD is a serious renal disorder characterized
by the development and gradual enlargement
of cysts in both kidneys.
The four-year patient recruitment
process started in January of 2001 and
already more than 50 patients with PKD have
agreed to participate in this new effort, called
the Consortium for Radiologic Imaging Studies
of PKD—or CRISP.

Normal kidneys with no disease (left)
Kidneys showing progression of PKD
(middle and right)
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PKD: A PROBLEMATIC PROGNOSIS

The CRISP team is targeting
the most common genetic kidney
disorder that affects some 600,000
people in the United States. PKD
can cause impaired renal function,
breathing problems, and bloating.
When cysts burst, patients also
may have bleeding, pain, and
infections. PKD patients are more
likely to face other serious problems as well, such as early-onset
hypertension, cerebral aneurysms,
and diverticular disease. As the
disease progresses, patients may
develop end-stage renal disease
(ESRD) and require dialysis or a
kidney transplant. PKD is the
fourth-leading cause of kidney failure requiring dialysis for survival
and accounts for five percent of
the ESRD population in the U.S. The
cost of PKD-related dialysis therapy
exceeds $200 million annually.
Not all patients with PKD
progress to ESRD. In fact, about
50 percent of PKD patients will
have a milder form of the disease,
with no impairment in renal function. Some of the risk factors for
progression to ESRD have been
identified, and the genes responsible for PKD (PKD-1 and PKD-2
genes) have been discovered.
The patients with the PKD-1
gene, accounting for 85 percent of
PKD population, tend to have an
earlier presentation of the disease
and a worse prognosis. The PKD-2
patients consist of 10 to 15 percent
of the population and have a
milder, late-disease manifestation.
Other high-risk factors for disease
progression include males,
African-Americans, people with
larger kidneys, and women who
have had three or more pregnancies.

Patients with PKD are usually
in their 40s or 50s before they go
to a doctor for diagnosis. And by
that time, their kidneys are consumed with cysts. Currently, there
is no medical therapy to slow or
stop the progression of this disease, but medications currently
being evaluated in clinical trial
may change that, says Bae.
Surgical alternatives also are
being investigated. Ralph Clayman, MD, a well-known endoscopic surgeon at Washington
University Medical Center, is evaluating the efficacy of laproscopic
cystectomy, a minimally invasive
procedure that reduces cyst burden. While 50 percent of patients
with PKD may not require medical
or surgical treatment, how can
physicians determine at an early
stage which patients are destined
to develop ESRD and do need
some kind of intervention?

THE CRISP STUDY

Currently, the imaging method
most often used to evaluate these
patients is ultrasound, an easily
accessible evaluation tool. But
ultrasound is not as reliable or as
accurate as MRI, which provides
high-resolution, three-dimensional
images with excellent tissue contrast. However, no large-scale trial
has ever been done to evaluate the
accuracy or validity of MRI in
assessing the progression of PKD.
"Presently, we cannot predict
whether a person will be in a highrisk group or a low-risk group,"
says Bae. "We can surmise that
because a patient is male and
PKD-1, he is at higher risk, but this
is not enough."
Bae is a radiologist with
expertise in body imaging as well
as image analysis, quantification,
and processing. However, when he
first responded to the National
Institutes of Health request for

MALLINCKRODT INSTITUTE OF RADIOLOGY

participation in the PKD study,
he was a first-year MIR faculty
member with no experience in
managing a large, multicenter trial.
Bae had to convince the NIH that
he could handle the job.
Within months, he assembled
a team of experts at Washington
University: Saulo Klahr, MD, is a
prominent nephrologist and editor
of the journal Kidney International. Phil Miller, Paul Thompson,
and Sarah Littlewood, from the
Division of Biostatistics, have
extensive experience in web-based
systems and in coordinating multicenter studies. Paul Commean, a
senior research engineer; Steve
Moore, a research assistant professor; and James Blaine, DSc, director of the Institute's Electronic
Radiology Laboratory (ERL), provide expertise in image transfer.
Mary Virginia Gaines, an MIR
research patient coordinator,
serves as project coordinator. Bae's
can-do attitude and expertise in
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image acquisition and analysis
convinced the NIH to award him
a $3 million grant.
The goal of the study, says
Klahr, is "to conduct a prospective,
longitudinal trial to evaluate the
accuracy and validity of MRI in
determining the progression of
autosomal-dominant PKD, defined
as a change in both renal and renal
cyst volumes over time." In this
trial, he says, MRI-based measurements become "the gold standard
in determining the extent of cystic
involvement over time."
Four institutions known for
PKD research and with existing
patient databases were brought in
to recruit and image the study participants: Emory University, University of Kansas, the Mayo Clinic,
and University of Alabama. Bae
then oversaw the development of
a strong imaging protocol, along
with a state-of-the-art, web-based
system for transferring images.
Mallinckrodt Institute was established as the study's Data Coordinating and Image Analysis Center
(DCIAC). The DCIAC would collect
images from the collaborating
institutions, segment and analyze
the images, make the statistical
analysis, and then properly store
and record the results using a
sophisticated data entry system.
To complement the imaging
data, each of the clinics is also
collecting clinical data to correlate
with the image analyses. Using a
web-based technology created by
Phil Miller and the group in Biostatistics, the clinic coordinators enter
the data into a database at the
DCIAC. This data will be used
to compute statistical correlations
between clinical, laboratory, and
genetic parameters and the progression of PKD as shown in the
images sent. From these analyses
it will be possible to answer ques-

pVolycystic
f kidney disease

Left: (left to right)
Paul Koppel, systems
manager; Jongdae Suh, MD,
research assistant;
Barry Brunsden,research
associate; and Jeong Rim Lee,
PhD, research associate.
Right: (left to right) Paul

tions about which patients are at
highest risk of developing ESRD.
An additional goal is to develop
cost effective methods to evaluate
new treatment strategies for PKD.
It took nearly a year to complete the final planning and development of the project as
participants met every six to eight
weeks at the NIH to discuss their
progress. Scanning techniques,
which varied slightly from one
institution to the other, had to be
standardized. As a quality control
measure, four patients were
recruited to travel from one site
to another, undergoing scans at
each site.
From the outset, the team did
not want to send patient films by
surface mail. Instead, they built a
secure network system, using software developed at Mallinckrodt
Institute, for transferring these
images electronically. "Once a
patient is scanned at any one of

the four participating institutions,
the MR and US image data first are
sent to a dedicated CRISP PC
workstation at that institution. The
confidential patient information is
'scrubbed' from the image headers,
and the image data are encrypted
for transmission via the Internet to
Mallinckrodt Institute for analysis
and storage," says Bae.
"Doctor Bae's personal leadership, approach to problem-solving,
and medical domain expertise have
been essential in working with the
four imaging centers to develop the
standardized imaging protocols
required for this study and have
guided the analysis team in the
ERL in establishing robust image
analysis techniques," says Blaine.
Mallinckrodt Institute will evaluate these images for a number of
variables: renal volume, cystic volume, and the percentage of cystic
involvement measured by MRI over
a specific time frame. By following

Commean, Steve Moore,
and Jim Blaine of the ERL
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these patients over time, the team
hopes to determine whether MRI
effectively assesses the changes in
renal or cystic volume and whether
these volume changes correlate with
functional changes in these patients.
Bae and his collaborators also want
to determine which of these factors
predict disease progression and will
compare the results of MRI and
ultrasound studies.
"We have to prove whether
the imaging is useful in identifying
these high-risk patients. If it is,
how can it be used to guide a
patient's treatment? Can imaging
help physicians monitor the
treatment and the progression
of disease?" says Bae.
The next few years will tell the
story, but the CRISP team is hopeful this research will make a difference for PKD patients. "This is a
very promising area to investigate
and will contribute to advancing the
treatment of PKD," adds Bae. Una

GRAPES, BALLOONS,
AND IMAGING
Along the way, Bae admits, there have been
some small, even humorous, obstacles to the
study. To test the accuracy and uniformity of the
measurements taken by all the cooperating institutions, his team had to build phantoms—models of
cyst-riddled kidneys—and send them out to the
study participants. But how to mimic a cyst? First
Bae tried grapes, which, unlike real cysts, did not
vary in size and were too quick to spoil, but he
learned that white grapes simulated cysts better
than red grapes. Then he tried small balloons.
"I filled the balloons with water, making
sure not to introduce any air. Then I tied the balloons with a very short string," he recalls. "It
must have taken me an hour to fashion only a
couple of the balloon cysts, but my wife mastered
the technique and made around two hundred
balloons for me."
That was only the beginning. These balloons
then had to be placed, very delicately, into a kidney-shaped mold filled with near-boiling agar
(a gelatinous colloidal medium). "And once I
thought the task was done, the balloon would
suddenly pop," Bae says. "So we had to train the
balloon, get it used to the hot water, and choose the
survivor before it was incorporated into the agar."

FOCAL SPOT, SPRING 2001

Parotid Gltind Sparing—How Much Is Enough"!

20 Gv.

wJm

By

60 Gv

Conventional radiation treatment of head and neck cancers requires high doses of
radiation to destroy the tumor tissue, but these
high levels often are indiscriminately destructive
to the surrounding normal tissues. These events
often lead to a number of irreversible side
effects, including xerostomia (dry mouth) associated with irradiation of the salivary glands.
Xerostomia can impact a patient's quality of life
by affecting taste, speech, swallowing, and
chewing, as well as contributing to dental
disease, frequent oral infections, and patient
self-esteem. At Mallinckrodt Institute of Radiology's (MIR) Radiation Oncology Center, recent
groundbreaking clinical results have proven that
a novel radiation treatment called intensity
modulated radiation therapy (IMRT) can greatly
reduce xerostomia without compromising the
radiation dose needed to destroy the tumor.

Heather Stieg, RT(T), a technologist, and Clifford
Chao, MD, prepare a patient for radiation treatment.
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INITIAL CLINICAL STUDIES
Head and neck cancers are a
significant healthcare concern in
the United States, where approximately 55,000 new cases and some
13,000 deaths are reported annually. Treatment of head and neck
cancers occurs through three
standard disciplines: surgery,
chemotherapy, and radiation
therapy. While chemotherapy and
surgery can be effective, they are
invasive and long-term treatment
regimens that harbor increased
risks, costs, and side effects.
Conventional radiation treatments
are broad-based systems for the
delivery of radiation to tumors, but
they often affect the surrounding
healthy tissue and can lead to significant side effects. Through the
use of computer-guided systems,
such as IMRT, radiation therapy
can be used in a highly selective
and noninvasive manner to attack
tumor tissue with minimal effects
on normal tissues.
IMRT is an advanced form of
conformal radiation therapy that
uses computer algorithms to generate complex, three-dimensional
radiation dose distributions specifically tailored to the individual
tumor volume. And yet the dose
can be escalated in order to
destroy the tumor but not affect
healthy organs, such as the salivary
glands. With IMRT, radiation is
administered through a reinforced,

individually fitted thermoplastic
mask designed to fit each patient's
head and neck area. The patient is
immobilized and lies on the bed of
a computed tomography scanner
while the machine acquires imaging information. Normal and target
tumor volumes are then delineated
by physicians, based on clinical
and radiological findings. Since
each patient's tumor size or shape,
as well as facial features, are
unique, the IMRT process requires
an incredible level of precision.
Nevertheless, according to
Clifford Chao, MD, assistant professor of radiology and principal
investigator of Mallinckrodt
Institute's IMRT study," IMRT
provides the opportunity to control
the tumor without substantially
affecting critical normal tissue."
A number of critical organs are
located in close proximity to head
and neck tumors, including the
spinal cord, brain stem, optic
systems, and salivary glands.
"Approximately seventy-five percent of patients in our study who
receive conventional radiation
treatments for head and neck
cancers exhibit moderate to severe
dry mouth," says Chao.
Xerostomia can be qualitatively measured by asking the
patient questions pertaining to
associated symptoms such as problems with speech, eating, drinking,
sleeping, or oral and dental health.
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Thermoplastic mask is fitted
specifically to each patient.

Xerostomia can also be measured
quantitatively by directly measuring the flow of saliva. Nonetheless,
xerostomia is usually pervasive and
permanent in most conventionally
irradiated patients, often leading to
severe quality of life changes
including lowered self-esteem.
According to Chao, the first
head and neck cancer patients
treated by IMRT came to the Institute in February of 1997. Since then
an additional 250 patients have
been treated. "Whereas other institutions treat more types of cancer
with IMRT, the Radiation Oncology
Center is the leading institution
in treatment of head and neck
cancer patients," he says. "We
have state-of-the-art equipment
and the best available computer
planning system."
In addition to the computers,
the IMRT treatment protocol
requires teamwork among physicians, physicists, dosimetrists,
consulting surgeons, medical
oncologists, diagnostic radiologists, and nurses. Overall, the
combined forces of superior
radiological treatment facilities
and integrated teamwork make
the Radiation Oncology Center an
ideal environment for Chao's
clinical studies to establish treatment protocols for head and neck
cancer patients.
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CLINICAL RESULTS
Initially, clinical studies were
performed to determine conformal
radiation therapy effects on head
and neck cancer patients through
forward or inverse planning protocols. Forward planning is the classical or conventional route of
radiation therapy where the team
determines all the variables and
proceeds by a trial-and-error
method. "Forward planning is a
very laborious process that
requires substantial time and effort
to determine the one combination
of various directions of radiation
beams, gantry angles, energy of
radiation, and type of radiation that
should be used," says Chao. "And
the worst part is that even when a
plan is set up, you cannot be sure
it is the best one. You do the best
you can, but you always feel there
may be a better one that has not
been explored."
Inverse planning is the opposite of forward planning, according
to Chao, in that the radiation oncologist designs the target, defines the
normal tissues, and estimates the
amount of radiation to deliver to a
particular region—and the computer determines how it will be
delivered.

The initial study of IMRT
involved 17 patients with varying
types of cancer, using either forward or inverse planning protocols.
The results were promising in that
tumors were controlled by IMRT
similar to conventional radiation
treatments. No severe side effects
were observed with IMRT, and
parotid gland (major salivary
gland) damage was reduced. Chao
indicates that inverse planning provided the best, achievable plan
because tumor and normal tissues
could be weighed separately.
In two additional clinical studies, Chao was able to support his
initial findings on tumor control
and to determine a correlation in
the amount of saliva produced to
the dose of radiation delivered to
the parotid gland. This hypothesis
was previously controversial
because other investigators have
been unable to pinpoint a direct
correlation. However, through
computer modeling and quantitative determinations of saliva flow,
Chao and his colleagues showed
that six months after IMRT treatment, patients exhibited a four percent drop exponentially in saliva
flow per Gy (Gy = gray, a standard
unit of radiation). Additionally,
Chao demonstrated that a decrease
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Results o-f Salivary Function

in saliva flow correlated both qualitatively and quantitatively with the
symptoms of xerostomia. Overall,
IMRT effectively targeted head and
neck tumors while reducing damage to salivary glands, leading to a
reduction of xerostomia.
Following the initial results,
additional head and neck cancer
patients were treated by IMRT, and
the treatment protocol has become
more efficient and standardized. In
the initial study IMRT treatment
took 45 minutes. "Now that we are
past the learning curve, treatment
time is down to twenty-five minutes," says Chao.
"The IMRT treatment technique is quite standardized at
Mallinckrodt Institute's Radiation
Oncology Center because we set
criteria based on earlier studies
and functional outcomes we have
gathered," adds Chao.
The goal of the earliest study
was to set up a treatment protocol
for patients that allowed the best
treatment of head and neck tumor
with parotid sparing or less xerostomia. However, as with any
treatment protocol there are
many variables and there exist
many different types of cancer
within the general head and neck
grouping. According to Chao, the
planning process was set up so
those patients with similar diseases
can be treated with similar protocols for the sake of consistency.
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FUTURE WORK
In the future Chao plans to
build on these studies and create a
tool for better understanding the
normal functional changes in the
major salivary glands, which
include the parotid, submandibular,
sublingual, and other minor saliva
glands. The main goal, according
to Chao, is to understand the exact
role of these glands in normal function and how each patient's quality
of life would be affected if the
glands were damaged.
Overall, Chao says that MIR's
Radiation Oncology Center now
has the proper tools and system to
treat head and neck cancers and
will continue to develop the infrastructure so that patients receive
the best treatment possible. "We
want to know the control rate,
functional outcome, and quality
of life effects the IMRT technique
will have on patients coming to
the Radiation Oncology Center,"
says Chao.
The effectiveness of the IMRT
treatment protocol on head and
neck cancer patients at the Institute has already elicited referrals.
The majority of patients are from
the St. Louis region but some
patients come from Chicago,
Kansas City, New York, and

Colorado as well as from other
countries, such as Israel. Ultimately,
by way of the superior teamwork
and modern facilities at MIR, Chao
hopes that "by using IMRT we can
improve the cancer cure rate and
eliminate the high costs associated
with tumor recurrence." EE!

IMRT STUDIES
COINVESTIGATORS
■ Joseph Deasy, PhD, assistant
professor of radiology
■ Joyce Taylor Haynie, RN, MSN
■ Daniel Low, PhD, assistant
professor of radiology
■ Carlos Perez, MD, professor of
radiology and director of the
Radiation Oncology Center
■ James Purdy, PhD, professor of
radiology and chief of radiation
physics
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FYI
In this section, the names of employees who are full-time faculty or staff or who have an appointment in the Department
of Radiology are highlighted in boldface type.

PROMOTIONS
Carmen Dence, MS,
research instructor in radiology, was promoted to
research scientist, Division of
Radiological Sciences.
Nobuo Horikoshi, MD,
instructor in radiology, was
promoted to assistant professor of radiology, Radiation
Oncology Center.
Eric Klein, MS, assistant
professor of radiology, was
promoted to associate professor of radiology, Radiation
Oncology Center.
Elizabeth McFarland, MD,
assistant professor of radiology, was promoted to associate professor of radiology,
Division of Diagnostic
Radiology.

Bruce Whiting, PhD,
instructor in radiology, was
promoted to research assistant professor of radiology,
Division of Radiological
Sciences.
Jie Zheng, PhD, instructor
in radiology, was promoted
to research assistant professor of radiology, Division of
Radiological Sciences.

NEW FACULTY
Samuel Achilefu, PhD,
associate professor of
radiology, Division of Radiological Sciences.
Zuofeng Li, DSc, assistant
professor of radiology,
Radiation Oncology Center.

Sasa Mutic, MS, instructor
in radiology, was promoted
to assistant professor of radiology, Radiation Oncology
Center.

JOINT
APPOINTMENT

Sandy Runs, MD, instructor
in radiology, was promoted
to assistant professor of radiology, Division of Diagnostic
Radiology.

Kathleen McDermott,
PhD, assistant professor of
psychology, was appointed
research assistant professor
of radiology, Division of
Radiological Sciences.

Sally Wagner-Schwarz,
MS, RPh, research instructor in radiology, was promoted to research scientist,
Division of Nuclear Medicine.

APPOINTMENTS/ELECTIONS
Carolyn Anderson, PhD,
associate professor of radiology, was appointed to the
Editorial Advisory Board of
the journal Bioconjugate
Chemistry. .

Susan Langhorst, PhD,
CHP, assistant professor of
radiology, was elected to a
six-year term on the National
Council on Radiation Protection and Measurements.

Kyongtae Bae, MD, PhD,
assistant professor of radiology, was selected for
membership in the Society of
Computed Body Tomography
and Magnetic Resonance.

Jeff Michalski, MD, assistant |
professor of radiology, was
named chair of the Radiation
Therapy Oncology Group's
(RTOG) Image-Guided Radiotherapy Committee.

Thomas Conturo, MD, PhD,
associate professor of radiology and adjunct associate
professor of physics and of
biomedical engineering, was
appointed to the National
Institutes of Health Special
Study Section SSS-X to review
neurology grants for medical
imaging.

Scott Mirowitz, MD, profes
sor of radiology and codirector of body magnetic
resonance imaging, was
elected to fellowship in the
American College of Healthcare Executives.

DeWitte Cross, MD, associate professor of radiology,
was appointed to a two-year
term on the Standards of
Practice Committee of
the American Society of
Interventional & Therapeutic
Neuroradiology.

Joel Perlmutter, MD, professor of neurology and of
radiology, was appointed as
a member of the Scientific
Advisory Board of the
American Parkinson Disease
Association.

Jay Heiken, MD, professor
of radiology, chief of abdominal radiology, and codirector
of body computed tomography, was appointed to the
American College of Radiology's Appropriateness Criteria
Expert Panel on Gastrointestinal Imaging.
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RANTS
irolyn Anderson, PhD,
sociate professor of radiiOgy, as principal investigator, received a $50,000 U.S.
jepartment of Defense
Brant for research on "Radiolabeled matrix metallopro|tt inase inhibitors for breast
pancer therapy." Coinvesti[ators for the one-year grant
Ire Jason Lewis, PhD,
(•( search instructor in radiolD >y, and Wen Ping Li, PhD,
(research associate.
fyongtae Bae, MD, PhD,
ssistant professor of radiolDgy, and Jack Engsberg, MD,
Df the Max Biedermann
nstitute, Switzerland, as
coprincipal investigators,
Received a two-year,
$30,000 foundation grant
[for research on "Center of
ravity in scoliosis."
Clifford Chao, MD, assisnt professor of radiology,
i principal investigator,
Received a $510,000
National Institutes of Health
rant for his research on
"Hypoxic image-guided
ntensity modulated radiotherapy." Coinvestigators
[for the four-year grant are
Walter Bosch, PhD,
instructor in radiology; Farrokh Dehdashti, MD, assoj date professor of radiology;
lark Mintun, MD, professor of radiology; Franz
Pippold, MD, associate
professor of radiology;
Samir El-Mofty, MD, Departnent of Pathology; Bruce
laughey, MD, Department of
\ Otolaryngology-Head and
•leek Surgery; and Kenneth
Schechtman, PhD, Division
!
of Biostatistics.
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GE-AUR
Fellowship
In 1999, Katie Vo, MD,
then a neuroradiology
fellow, was one of four
radiology investigators
nationwide to receive a
GE-AUR Radiology
Research Academic
Fellowship. The twoyear General ElectricAssociation of University Radiologists fellowships encourage young investigators to
pursue careers in radiology research. Vo, now an MIR faculty member, is shown at
the official 2000-2001 stipend presentation with (left to right) Greg Thudium, corporate account manager, GE Medical Systems; Gary Brink, director of radiology,
Barnes-Jewish Hospital; Gilbert Jost, MD, professor and interim director of Mallinckrodt Institute; and Tony Scaduto, regional sales manager, GE Medical Systems.

Thomas Conturo, MD,
PhD, associate professor of
radiology and adjunct associate professor of physics
and of biomedical engineering, as principal investigator,
received a $2.1 million
National Institutes of
Health/National Institute of
Neurological Disorders and
Stroke grant for "Tracking
neuronal fibers in the living
human brain by MRI." Coinvestigators for the five-year
grant are Erbil Akbudak,
PhD, research instructor in
radiology; Abraham Snyder, PhD, MD, research scientist of radiology; Joshua

Shimony, PhD, MD, clinical
fellow in neuroradiology;
Harold Burton, PhD, professor of neurology and of
radiology; Maurizio Corbetta, MD, assistant professor of neurology and of
radiology; Nicolas Lori,
graduate research assistant
in radiology; and Gordon
Shulman, PhD, Department
of Neurology. Consultants
are Marcus Raichle, MD,
professor of radiology and of
neurology and neurobiology;
David Van Essen, PhD,
Department of Anatomy and
Neurobiology; and William
Hart, MD, PhD, Department
of Ophthalmology.

James Duncan, MD, PhD,
assistant professor of radiology, received a $25,000
award from the Cardiovascular and Interventional
Radiology Research and
Education Foundation for
his project "Hepatic gene
therapy in neonates."
Katherine Ponder, PhD,
Department of Internal Medicine, is coinvestigator.
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GRANTS
Continued from page 23
Eduardo Moros, PhD,
associate professor of radiology, as principal investigator, received a $1 million
National Institutes of
Health/National Cancer Institute grant for his research on
"Ultrasonic systems for
simultaneous thermoradiotherapy." Coinvestigators
for the five-year grant are
Robert Myerson, PhD,
MD, professor of radiology;
William Straube, MS,
instructor in radiology; and
Eric Klein, MS, associate
professor of radiology.
Pratik Mukherjee, MD,
clinical fellow in neuroradiology, as principal investigator, received a $50,000
Berlex/ASNR Fellowship in
Basic Science Research from
the American Society of
Neuroradiology for his project "Comparison of magnetic resonance imaging
with positron emission
tomography in the study of
cerebral hemodynamics."
Colin Derdeyn, MD, assistant professor of radiology,
is Mukherjee's sponsor for
the one-year grant.
Joel Perlmutter, MD, professor of neurology and of
radiology, as principal investigator, received a $1.1 million grant from the National
Institutes of Health/National

Institute of Neurological
Disorders and Stroke for
research on "Mechanisms
of deep brain stimulation."
Coinvestigators for the
three-year grant are
Jonathan Mink, MD, Department of Neurology; Tom
Videen, PhD, research professor of neurology and of
radiology; Tamara Hershey,
MD, Department of Psychiatry; Stephen Moerlein,
PhD, associate professor
of radiology; and Lori
McGee-Minnich, Department
of Neurology.
Nikolaos Tsekos, PhD,
assistant professor of radiology, received a two-year
grant from the American
Heart Association in the
amount of $70,000 for his
research on "Assessment of
myocardial sodium and high
energy phosphates on the
ischemic and reperfused
heart with MR techniques."
He received a three-year,
$210,00 grant from the
Whitaker Foundation to
study "Methods for dynamic
magnetic resonance imaging
and spectroscopy of the
heart." Tsekos received a
one-year Seed Cycle 1 award
in the amount of $24,000
from the Radiological Society of North America for his
project "Assessment of
myocardial blood flow with
magnetization transfer contrast MRI."

Biello Lecture
At the Fifteenth Annual Daniel R. Biello
Memorial Lecture on March 12, Sanjiv Gambhir, MD, PhD, head of the Bio-Imaging Assay
Laboratory, Crump Institute for Biological
Imaging, University of California, Los Angeles,
spoke on "Advances in molecular imaging for
imaging gene expression." Barry Siegel, MD,
(left) professor of radiology and director of
the Division of Nuclear Medicine, coordinates
the Biello Lecture.
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(HONORS/
AWARDS
' Carlos Perez, MD, professor of radiology and director
Df the Radiation Oncology
Center, was named chairperson for the Radiological
I Protection of Patients in
Radiation Therapy Session
for the International Conference on the Radiological
Protection of Patients in
Diagnostic and Interventional Radiology, Nuclear
I Medicine, and Radiolerapy, held March 26-30
L Malaga, Spain.
lerold Wallis, MD, associI ate professor of radiology,
I was named organizer of the
Society of Nuclear Medicine
lidwinter Symposium on
"Using the Internet for Televluclear Medicine" held in
February in Tampa, Florida.
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LECTURES/PRESENTATIONS
Carolyn Anderson, PhD,
associate professor of radiology, presented "Radiopharmaceuticals for cancer
imaging and therapy" at Central Missouri State University, Warrensburg, Missouri,
February 8.
Kyongtae Bae, MD, PhD,
assistant professor of radiology, spoke on "The evolving
role of MRCP in pancreatobiliary disease" at A Galaxy
of Gastroenterology, sponsored by Washington University School of Medicine's
Continuing Medical Education office, St. Louis,
Missouri, March 9.
Thomas Conturo, MD,
PhD, associate professor of
radiology and adjunct associate professor of physics and
of biomedical engineering,
as invited speaker, presented
"White matter fiber tractography" at the National Institutes of Health Diffusion
Tensor MRI (DT-MRI) Conference: From Bench to Bedside, Bethesda, Maryland,
December 6 and 7. He spoke
on "Functional magnetic resonance imaging for neuroscience research" at the MR
Imaging and Spectroscopy
Center, Louisville, Kentucky,
January 11 and 12.

Maurizio Corbetta, MD,
assistant professor of neurology and of radiology, presented "Mapping of visual
systems in the human brain"
at the European School of
Functional Magnetic Resonance Imaging, Utrech, Holland, January 13. He spoke
on "Attentional networks or
attentional tricks" at the
International Neuropsychological Society meeting,
Chicago, Illinois, February 17.
DeWitte Cross, MD, associate professor of radiology,
spoke on "CNS thrombolysis" at the South Carolina
Upstate Neurovascular Symposium, Greenville, South
Carolina, March 17.
Colin Derdeyn, MD, assistant professor of radiology,
presented "Late thromboembolic events after treatment
of intracranial aneurysms
with GDC" at the American
Heart Association Annual
Stroke Meeting, Fort Lauderdale, Florida, February 16.
Perry Grigsby, MD, MBA,
professor of radiology,
spoke on "Radiotherapy for
stage IB carcinoma of the
cervix" at the 9th Annual
Conference of the Association of Gynaecologic Oncologists of India, Gwalior, India,
December 1-3.

Jay Heiken, MD, professor
of radiology, chief of abdominal radiology, and codirector of body computed
tomography, presented
"Characterization of liver
tumors with CT and MRI:
Part 1—benign lesions;"
"Characterization of liver
tumors with CT and MRI:
Part 2—malignant lesions;"
and "Pancreatic carcinoma:
detection and staging with
CT" at the Annual Course of
Radiology, The Mexican
Society of Radiology and
Imaging, Mexico City, Mexico, February 1-5. He spoke
on "Hepatic masses: characterization with CT and MRI;"
"Imaging evaluation of renal
masses;" "Helical CT of the
urinary tract;" "Imaging of
nontraumatic emergencies
of the gastrointestinal tract;"
and "CT colonography: state
of the art" at Advances in
Imaging: 2001, sponsored
by Louisiana State University
and Tulane University
Health Science Centers,
Breckenridge, Colorado,
February 18-23.
Anil Khosla, MD, instructor
in radiology, spoke on
"Intracranial manifestations
of systemic cancer—imaging
issues" and "Diffusion imaging in neurological diagnosis" at the All India Institute
of Medical Sciences, New
Delhi, India, March 20.
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LECTURES/PRESENTATIONS
Continued from page 25
Eric Klein, MS, associate
professor of radiology, presented "The conformal and
intensity modulated therapy
programs at Mallinckrodt
Institute" and "Physics
issues with DMLC delivery"
at the University of Michigan, Ann Arbor, Michigan,
March 15.
Jason Lewis, PhD, research
instructor in radiology, presented "Cu-64-bis(thiosemicarbazone) complexes as
agents for diagnosis and
radiotherapy" at the 2000
International Chemical
Congress of Pacific Basin
Societies, Honolulu, Hawaii,
December 18.

Elizabeth McFarland, MD,
associate professor of radiology, spoke on "Dimensional
CT angiography of endovascular aortic stent grafts"
at the Midwest Regional Noninvasive Vascular Society, St.
Louis, Missouri, February 15.
Robert McKinstry, MD,
PhD, assistant professor of
radiology, presented "Web
resources for physicians,"
"Web resources for consumers," "Solutions for
enhancing your practice,"
and "Authentication and
Internet security" at the
American Medical Association (AMA) House of Dele-

RSNA honors
At the 86'" Annual Scientific Meeting of the Radiological Society of North America, held in Chicago, Illinois,
November 26 through December 1, 2000, Anil
Khosla, MD, instructor in radiology, was a multiple
winner of the Case of the Day: Sunday for cardiac,
nuclear medicine, and ultrasound; Monday for cardiac
and neuroradiology. Medhi Poustchi-Amin, MD,
clinical fellow in magnetic resonance imaging,
received a Certificate of Merit for the scientific
exhibit "Practical cardiac MRI."

gates Interim Meeting, Internet Health Roadshow,
Orlando, Florida, December
4. He spoke on "Novice Internet training," "Introduction to
Internet solutions," "Using
Internet applications," and
"Creating Web sites" at the
AMA Internet Health Roadshow, Jackson, Mississippi,
February 27, and at the AMA
National Leadership Development Conference Internet
Health Roadshow, Washington, DC, March 3 and 4.
Jeff Michalski, MD, assistant professor of radiology,
spoke on "Techniques and
management of patients
receiving prostate
brachytherapy" and
"Advances in radiation therapy of prostate cancer" at
the University of Louisville
Hospital, Louisville, Kentucky, December 5 and 6. He
presented "3D conformal
radiation therapy and traditional therapy" at the Radiation Therapy Oncology
Group/Patient Advocacy
Committee Meeting, Tampa,
Florida, February 9. He presented "Debate: IMRT only

for major referral centers" to
the American Society of
Therapeutic Radiation
Oncologists, Chicago, Illinois, March 9. Michalski
spoke on "The role of hormonal therapy in the treatment of prostate cancer" at
the AstraZeneca Speaker's
Bureau/Illinois Oncology
Nurses Society meeting,
Springfield, Illinois, March
14. He presented "Innovations in radiation therapy for
prostate cancer" at Inova
Fairfax Hospital, Falls
Church, Virginia, March 29.
Mark Mintun, MD, professor of radiology, as invited
lecturer, spoke on "Brain
mapping with PET and
SPECT" at the 39th Annual
Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico,
December 10.
Stephen Moerlein, PhD,
associate professor of radiology, presented "Preparation
of flumazenil Cll injection
for PET measurement of
benzodiazepine receptor
activity" at the 148th Annual
Meeting of the American
Pharmaceutical Association
San Francisco, California,
March 16-20.
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Carlos Perez, MD, professor
of radiology and director of
the Radiation Oncology Center, spoke on "Preoperative
short duration radiation therapy versus conventional radiation for rectal cancer;"
"Permanent implants in
prostate cancer: indications,
contraindications, and
results;" "Cancer of the
tongue and mouth floor:
When radiation therapy is
indicated;" "Cancer of the
ongue and mouth floor:
hemoirradiation;" "Cancer of
e tongue and mouth floor:
anagement of radiation toxicity;" and "Complications
•elated to the use of radiation
.erapy" at XV Congresso
Brasileiro de Cancerologia,
Salvador, Bahia, Brazil,
ovember 26-30. He spoke on
"Place of radiation therapy in
the management of breast
cancer," "Radiation therapy
echniques in the manageent of breast cancer," and
Multimodality treatment of
locally advanced breast canleer" at the 4"1 United Arab
narrates International Cancer Conference, Abu Dhabi,
nited Arab Emirates, Janu28-31. He presented "Ecoomics of different treatment
ptions in prostate" at the
ucletron's High-Dose Rate
onotherapy Brachytherapy
eeting, San Francisco, Calibrnia, February 16. He preented "The role of radiation
erapy in modern clinical
neology" at the Hadrotherpy Conference, Trento, Italy,
ebruary22. Perez spoke on
Metastatic bone pain" at the
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Thomas Jefferson Hospital,
Philadelphia, Pennsylvania,
March 21, and at the Department of Radiation Oncology,
Erie Regional Cancer Center,
Erie, Pennsylvania, April 10.

Joel Perlmutter, MD, professor of neurology and of
radiology, spoke on "Altered
cortical blood flow response
to L-dopa in chronically
L-dopa treated Parkinson's
disease" and "Blood flow

responses to deep brain stimulation of the thalamus in
essential tremor" at the 7"'
International Meeting of The
Basal Ganglia Society, Bay
of Islands, New Zealand, February 12.

Senturia Lecture
On February 12, James Thrall, MD, professor and chairman, Department of Radiology, Massachusetts General Hospital, presented the Seventh Annual Hyman R.
Senturia Lecture, "Managing change in twenty-first century radiology practice."
Shown with Thrall (right) is Scott Mirowitz, MD, professor of radiology and
coordinator of the Senturia Lecture.
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LECTURES/PRESENTATIONS
Continued from page 27
Mehdl Poustchi-Amin, MD,
clinical fellow in magnetic
resonance imaging, presented
"MRI of the knee: normal variants, diagnostic pitfalls, and
artifacts;" "MRI of the shoulder: normal variants, diagnostic pitfalls, and artifacts;" and
"Practical cardiac MRI: principles and applications. A
review for the general radiologist" at the American Roentgen Ray Society Annual
Meeting, Seattle, Washington,
April 29-May 4.
Stuart Sagel, MD, professor
of radiology, chief of chest
radiology, and codirector of
body computed tomography,
spoke on "CT angiography for
pulmonary embolism," "CT of
the pleura," "CT of non-vascular mediastinal masses," and
"Role of CT in bronchogenic
carcinoma" at the 171" Annual
Computed Body Tomography
Course: The Cutting Edge,
Orlando, Florida, February
15-18. As visiting professor,
he presented "CT angiography for pulmonary
embolism,"" CT of the thorax: anatomic variants and
pitfalls," and "Role of CT in
bronchogenic carcinoma" to
the Department of Radiology,
University of California, San
Diego, March 5 and 6.

Vijay Sharma, PhD, assistant professor of radiology,
presented "Novel gallium(ni)
complexes as potential PET
imaging agents for probing
multidrug resistance (MDR1)
P-glycoprotein (Pgp): effect of
MDR reversal agents" at the
American Chemistry Society
Pacifichem 2000 Meeting,
Honolulu, Hawaii, December
14-19.
Barry Siegel, MD, professor
of radiology and of medicine,
and director of the Division of
Nuclear Medicine, presented
"Applications of PET in
oncology" at Mount Sinai
Medical Center and at Baptist
Medical Center, Miami Beach,
Florida, February 2.
Marilyn Siegel, MD, professor of radiology and of pediatrics, spoke on "The
differential diagnosis and
postnatal management of prenatally detected pyelectasis,"
"Intracranial hemorrhage in
the neonate and infant," and
"The acute pediatric
abdomen" at the British Medical Ultrasound Society, Eastbourne, United Kingdom,
December 5-7. As visiting
professor, she presented
"MR/CT of common pediatric
abdominal tumors" and
"Ultrasonography of the acute
pediatric abdomen" at Yale
University, New Haven, Connecticut, March 1. Siegel
spoke on "Ultrasonography of
intracranial hemorrhage and
ischemia" and "Sonography of
acute right lower quadrant
pain in children" at the 45th
Annual Convention of the
American Institute of Ultrasound in Medicine, Orlando,
Florida, March 11 and 12.

Jerold Wallis, MD, associate professor of radiology,
presented "Third party tools
for tele-nuclear medicine" at
the Society of Nuclear Medicine Midwinter Symposium,
Tampa, Florida, February 10.
Todd Wasserman, MD, professor of radiology, presented
"Long-term toxicity of radiation therapy for Hodgkin's
disease" at the Rabin Medical
Center, Tel Aviv University,
Petach Tikva, Israel, December 15. He presented "Protectors" to the Cancer Education
Program-Tumor Board,
Elkhart General Healthcare
System, Elkhart, Indiana,
December 20, and at the
Lakeland Continuing Medical
Education Center, St. Joseph,
Michigan, March 22. Wasserman spoke on "Radioprotection in oncology" at Grand
Rounds, Northwestern Memorial Hospital/Northwestern
University Cancer Center,
Chicago, Illinois, January 19.

SYMPOSIUM
In this section ofFYI, only
those faculty and staff who
have MIR appointments are
listed.

SOCIETY OF COMPUTED
BODY TOMOGRAPHY
AND MAGNETIC
RESONANCE
Twenty-fourth Annual Course |
South Beach, Florida
March 19-23, 2001
Stuart Sagel, MD, Interactive Case Session: Chest.
WORKSHOP I
Stuart Sagel, MD, "CT of
the thorax: anatomic variants and pitfalls."
WORKSHOP II
Jay Heiken, MD, "Liver
lesion characterization."
WORKSHOP III
Stuart Sagel, MD, "CT of
the thorax: anatomic variants and pitfalls."
Marilyn Siegel, MD, "Pedi
atric imaging: techniques
and oncology."
2ND SUB: WORKSHOP IV
Stuart Sagel, MD, "CT of
mediastinal masses."
Marilyn Siegel, MD, "MRI
of musculoskeletal masses.'
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(Left to right) Douglas Curry, MD;
Sailendra Naidu, MD; and
James Goddard, MD.

' .. '

OCAL

ivfAf:r;riTr:r-"Rrjr/fri prt'rrrrt'w ufJiALilDioa?

Address Service Requested
Send distribution changes or
address corrections to
Focal Spot editor
Mallinckrodt Institute
of Radiology at
Washington University
Campus Box 8131
510 South Kingshighway Blvd.
St. Louis, MO 63110
(314) 362-2866

Editor and Writer
Vicki Kunkler
Contributing Writers
Candace O'Connor
Thomas Peters
Barbra Rodriguez
Photographers
Steve Frazier
TomMurry
Tim Parker
Michelle Wynn
Design

urviance & Company
Marketing Communications
Printing

Scholin Printing Company
ocal Spot magazine is
distributed three times annually.
Magazine articles may be
reproduced if credit is given
to Focal Spot magazine of the
Mallinckrodt Institute of
Radiology at Washington
University in St. Louis.
O Mallinckrodt Institute of
Radiology, 2001

J Washington

JniversityinStLouis

ICHOOL OF MEDICINE

MIR

iodt Institute

«i

